Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Instil Bio, Inc. Director's Dealing 2022

Sep 6, 2022

33728_dirs_2022-09-06_0b206fd4-f94a-40d5-975b-38dfe4290bf7.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Instil Bio, Inc. (TIL)
CIK: 0001789769
Period of Report: 2022-09-06

Reporting Person: MOORE TIMOTHY L. (Chief Operating Officer)